Organovo signs drug discovery agreement with J & J unit

|About: Organovo Holdings, Inc. (ONVO)|By:, SA News Editor

Shares of Organovo (NYSEMKT:ONVO) are up 17% premarket on robust volume in response the signing of a research agreement with Johnson & Johnson unit Janssen Research and Development to evaluate the use of 3D bio-printed tissue in drug discovery. Financial terms are not disclosed.